Showing results (241-250 of 745) with videos related to
Sort By:
Pageof 75
Neurogastroenterology and Motility|January 25, 2011
Factors associated with co-morbid irritable bowel syndrome and chronic fatigue-like symptoms in functional dyspepsiaL Van Oudenhove, J Vandenberghe, R Vos, et al.The American Journal of Medicine|August 1, 1982
Aspergillus osteomyelitis. Report of four cases and review of the literatureK J Tack, F S Rhame, B Brown, et al.Alimentary Pharmacology & Therapeutics|July 18, 2006
Systematic review: the efficacy of treatments for irritable bowel syndrome--a European perspectiveJ Tack, M Fried, L A Houghton, et al.Diabetic Medicine : a Journal of the British Diabetic Association|January 30, 2007
Increased forearm blood flow in longstanding Type 1 diabetic patients without microvascular complicationsP J van Gurp, J W M Lenders, C J TackAntimicrobial Agents and Chemotherapy|April 1, 1997
Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. The Cefdinir Pediatric Skin Infection Study GroupK J Tack, C H Keyserling, J McCarty, et al.Gut|October 30, 2007
Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trialsN J Talley, J Tack, T Ptak, et al.The American Journal of Gastroenterology|July 27, 2001
The role of acid and duodenal gastroesophageal reflux in symptomatic GERDG H Koek, J Tack, D Sifrim, et al.Neurogastroenterology and Motility|August 5, 2017
Intragastric infusion of the bitter tastant quinine suppresses hormone release and antral motility during the fasting state in healthy female volunteersE Deloose, M Corsetti, L Van Oudenhove, et al.Alimentary Pharmacology & Therapeutics|March 19, 2003
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjectsA P S Hungin, P J Whorwell, J Tack, et al.Gut|September 13, 2003
Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitorsG H Koek, D Sifrim, T Lerut, et al.Pageof 75